Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cardiothoracovascular Department, Cattinara Hospital, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
JAMA Cardiol. 2022 Apr 1;7(4):378-385. doi: 10.1001/jamacardio.2021.6016.
A high burden of premature ventricular contractions (PVCs) at disease diagnosis has been associated with an overall higher risk of ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). Data regarding dynamic modification of PVC burden at follow-up with Holter monitoring and its impact on arrhythmic risk in ARVC are scarce.
To describe changes in the PVC burden and to assess whether serial Holter monitoring is dynamically associated with sustained ventricular arrhythmias during follow-up in patients with ARVC.
DESIGN, SETTINGS, AND PARTICIPANTS: In this cohort study, patients with a definite ARVC diagnosis, available Holter monitoring results at disease diagnosis, and at least 2 additional results of Holter monitoring during follow-up were enrolled from 6 ARVC registries in North America and Europe. Data were collected from June 1 to September 15, 2021.
The association between prespecified variables retrieved at each Holter monitoring follow-up (ie, overall PVC burden; presence of sudden PVC spikes, defined as absolute increase in PVC burden ≥5000 per 24 hours or a relative ≥75% increase, with an absolute increase of ≥1000 PVCs; presence of nonsustained ventricular tachycardia [NSVT]; and use of β-blockers and class III antiarrhythmic drugs) and sustained ventricular arrhythmias occurring within 12 months after that Holter examination was assessed using a mixed logistical model.
In 169 enrolled patients with ARVC (mean [SD] age, 36.3 [15.0] years; 95 men [56.2%]), a total of 723 Holter examinations (median, 4 [IQR, 4-5] per patient) were performed during a median follow-up of 54 (IQR, 42-63) months and detected 75 PVC spikes and 67 sustained ventricular arrhythmias. The PVC burden decreased significantly from the first to the second Holter examination (mean, 2906 [95% CI, 1581-4231] PVCs per 24 hours; P < .001). A model including 24-hour PVC burden (odds ratio [OR] 1.50 [95% CI, 1.10-2.03]; P = .01), PVC spikes (OR, 6.20 [95 CI, 2.74-13.99]; P < .001), and NSVT (OR, 2.29 [95% CI, 1.10-4.51]; P = .03) at each follow-up Holter examination was associated with sustained ventricular arrhythmia occurrence in the following 12 months.
These findings suggest that in patients with ARVC, changes in parameters derived from each Holter examination performed during follow-up are associated with the risk of sustained ventricular arrhythmias within 12 months of disease diagnosis.
在致心律失常性右心室心肌病 (ARVC) 中,疾病诊断时过早室性收缩 (PVC) 的负担较高与室性心律失常的总体风险增加有关。关于动态 Holter 监测随访中 PVC 负担的变化及其对 ARVC 心律失常风险的影响的数据很少。
描述 PVC 负担的变化,并评估 ARVC 患者在随访期间连续 Holter 监测是否与持续性室性心律失常动态相关。
设计、地点和参与者:在这项队列研究中,纳入了来自北美和欧洲的 6 个 ARVC 注册中心的具有明确 ARVC 诊断、可获得疾病诊断时 Holter 监测结果以及至少 2 次随访 Holter 监测结果的患者。数据于 2021 年 6 月 1 日至 9 月 15 日收集。
使用混合逻辑模型评估每个 Holter 监测随访时预设变量(即总体 PVC 负担;出现突然 PVC 尖峰,定义为绝对增加≥ 5000 个/24 小时或相对增加≥ 75%,绝对增加≥ 1000 个 PVC;出现非持续性室性心动过速 [NSVT];β受体阻滞剂和 III 类抗心律失常药物的使用)与该 Holter 检查后 12 个月内发生的持续性室性心律失常之间的关联。
在 169 名患有 ARVC 的入组患者(平均[标准差]年龄为 36.3[15.0]岁;95 名男性[56.2%])中,中位数为 4(IQR,4-5)次/患者,中位随访时间为 54(IQR,42-63)个月,共进行了 723 次 Holter 检查,检测到 75 次 PVC 尖峰和 67 次持续性室性心律失常。从第一次 Holter 检查到第二次 Holter 检查,PVC 负担明显下降(平均 24 小时内 2906[95%CI,1581-4231]个 PVC;P<0.001)。包括 24 小时 PVC 负担(比值比[OR]1.50[95%CI,1.10-2.03];P=0.01)、PVC 尖峰(OR,6.20[95%CI,2.74-13.99];P<0.001)和 NSVT(OR,2.29[95%CI,1.10-4.51];P=0.03)的每个随访 Holter 检查的模型与疾病诊断后 12 个月内持续性室性心律失常的发生相关。
这些发现表明,在 ARVC 患者中,在随访期间进行的每次 Holter 检查中得出的参数变化与 12 个月内持续性室性心律失常的风险相关。